Philip Beale

12.3k total citations
227 papers, 5.9k citations indexed

About

Philip Beale is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Philip Beale has authored 227 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Oncology, 41 papers in Molecular Biology and 37 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Philip Beale's work include Metal complexes synthesis and properties (51 papers), Colorectal Cancer Treatments and Studies (31 papers) and Ferrocene Chemistry and Applications (30 papers). Philip Beale is often cited by papers focused on Metal complexes synthesis and properties (51 papers), Colorectal Cancer Treatments and Studies (31 papers) and Ferrocene Chemistry and Applications (30 papers). Philip Beale collaborates with scholars based in Australia, United States and United Kingdom. Philip Beale's co-authors include Stephen Clarke, Fazlul Huq, Jun Yu, Ian Judson, Jane Read, Trevor W. Hambley, Matthew D. Hall, Phyllis Butow, Martin R. Stockler and Fazlul Huq and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Philip Beale

216 papers receiving 5.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip Beale Australia	41	2.8k	1.2k	1.1k	729	651	227	5.9k
Peter Nygren Sweden	47	2.7k 1.0×	2.8k 2.3×	768 0.7×	336 0.5×	385 0.6×	234	7.0k
Wanghong Xu China	46	1.1k 0.4×	1.8k 1.5×	505 0.5×	338 0.5×	309 0.5×	217	7.1k
François Goldwasser France	48	4.7k 1.7×	2.8k 2.4×	2.1k 1.9×	286 0.4×	205 0.3×	289	8.9k
Peter Greenwald United States	43	1.7k 0.6×	1.6k 1.3×	701 0.7×	245 0.3×	236 0.4×	156	6.5k
James T. Dalton United States	55	1.4k 0.5×	3.4k 2.9×	2.1k 1.9×	1.6k 2.2×	219 0.3×	203	9.6k
Kathy J. Helzlsouer United States	58	2.5k 0.9×	2.6k 2.2×	777 0.7×	237 0.3×	362 0.6×	156	9.9k
Angela N. Giaquinto United States	7	3.0k 1.1×	2.5k 2.1×	1.8k 1.7×	247 0.3×	218 0.3×	10	7.6k
James T. Cassidy United States	40	2.9k 1.0×	1.6k 1.4×	1.2k 1.1×	291 0.4×	120 0.2×	106	7.2k
Zahid H. Siddik United States	39	4.6k 1.6×	3.8k 3.3×	1.1k 1.0×	1.3k 1.7×	536 0.8×	154	9.4k
Staffan Eksborg Sweden	46	1.1k 0.4×	1.2k 1.0×	494 0.5×	174 0.2×	212 0.3×	254	6.4k

Countries citing papers authored by Philip Beale

Since Specialization

Citations

This map shows the geographic impact of Philip Beale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Beale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Beale more than expected).

Fields of papers citing papers by Philip Beale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Beale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Beale. The network helps show where Philip Beale may publish in the future.

Co-authorship network of co-authors of Philip Beale

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Beale. A scholar is included among the top collaborators of Philip Beale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Beale. Philip Beale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Galettis, Peter, et al.. (2023). Comparison of capecitabine concentrations determined by microsampling versus plasma concentrations for therapeutic drug monitoring: a pilot study. Journal of Pharmacy and Pharmacology. 76(2). 86–92. 1 indexed citations

Lee, Yeh Chen, Hao‐Wen Sim, Judy Kirk, et al.. (2023). Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinoma. Translational Oncology. 31. 101638–101638.

Butow, Phyllis, Ilona Juraskova, Louise Sharpe, et al.. (2023). Stakeholder perspectives on the impact of COVID-19 on oncology services: a qualitative study. Supportive Care in Cancer. 31(8). 491–491. 1 indexed citations

Tan, David S.P., Noriko Fujiwara, Keiichi Fujiwara, et al.. (2023). The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women’s cancer research organization. Journal of Gynecologic Oncology. 34(2). e33–e33.

Smith, Deborah S., Kristy Robledo, Sonia Yip, et al.. (2022). Results of PD-L1 Analysis of Women Treated with Durvalumab in Advanced Endometrial Carcinoma (PHAEDRA). Cancers. 15(1). 254–254. 1 indexed citations

Laidsaar‐Powell, Rebekah, Jane Young, Daniel Steffens, et al.. (2022). Work: saviour or struggle? A qualitative study examining employment and finances in colorectal cancer survivors living with advanced cancer. Supportive Care in Cancer. 30(11). 9057–9069. 13 indexed citations

Kwok, John B., Rebecca Asher, Chee Khoon Lee, et al.. (2017). Clinical and genetic predictors of paclitaxel neurotoxicity based on patient- versus clinician-reported incidence and severity of neurotoxicity in the ICON7 trial. Annals of Oncology. 28(11). 2733–2740. 56 indexed citations

Perren, Timothy, W. Schroeder, Éric Pujade-Lauraine, et al.. (2013). ICON7: Final overall survival results in the GCIG phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer. UCL Discovery (University College London). 21 indexed citations

Beale, Philip, et al.. (2013). Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models. Journal of Ovarian Research. 6(1). 78–78. 21 indexed citations

10.

Pujade-Lauraine, Éric, Timothy Perren, Sven� Mahner, et al.. (2013). ICON7: FINAL OVERALL SURVIVAL RESULTS IN THE GCIG PHASE III RANDOMISED TRIAL OF BEVACIZUMAB IN NEWLY DIAGNOSED OVARIAN CANCER. UCL Discovery (University College London). 6 indexed citations

11.

Beale, Philip, et al.. (2012). Studies on combination of platinum drugs cisplatin and oxaliplatin with phytochemicals anethole and curcumin in ovarian tumour models.. PubMed. 32(11). 4843–50. 38 indexed citations

12.

Beale, Philip, et al.. (2011). Synergism from the combination of oxaliplatin with selected phytochemicals in human ovarian cancer cell lines.. PubMed. 31(12). 4283–9. 24 indexed citations

13.

Oh, Byeongsang, Phyllis Butow, Barbara Mullan, et al.. (2010). Patient-doctor communication: use of complementary and alternative medicine by adult patients with cancer.. eSpace (Curtin University). 8(2). 56–64. 33 indexed citations

14.

Chapuis, Pierre H., E. Leslie Bokey, Stephen Clarke, Philip Beale, & Owen F. Dent. (2009). Adjuvant chemotherapy for stage C colonic cancer in a multidisciplinary setting. ANZ Journal of Surgery. 79(10). 685–692. 4 indexed citations

15.

Oh, Byeongsang, Phyllis Butow, Barbara Mullan, et al.. (2009). Impact of Medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial. Annals of Oncology. 21(3). 608–614. 167 indexed citations

16.

Cheng, Hengmiao, et al.. (2006). Synthesis, characterisation, activities, cell uptake and DNA binding of a trinuclear complex: [{trans-PtCl(NH3)}2μ-{trans-Pd(NH3)(2-hydroxypyridine)-(H2N(CH2)6NH2)2]Cl4. European Journal of Medicinal Chemistry. 41(7). 896–903. 36 indexed citations

17.

Huq, Fazlul, et al.. (2006). Studies on the synthesis and characterization, and binding with DNA of two Cis-Planaramineplatinum(II) complexes of the forms: Cis-PtL2Cl2 and Cis-PtL(NH3)Cl2 and where L=3-Hydroxypyridine and Imidazo(1,2-a) Pyridine. Queensland's institutional digital repository (The University of Queensland). 1(1). 91–100. 5 indexed citations

18.

Hall, Matthew D., Carolyn T. Dillon, Mei Zhang, et al.. (2003). The cellular distribution and oxidation state of platinum(II) and platinum(IV) antitumour complexes in cancer cells. JBIC Journal of Biological Inorganic Chemistry. 8(7). 726–732. 132 indexed citations

19.

Ackland, Stephen P., Philip Beale, & Godefridus J. Peters. (2003). Thymidylate synthase inhibitors. PubMed. 20. 1–28. 12 indexed citations

20.

Beale, Philip, Ruth Plummer, Martin Highley, et al.. (1998). Phase I trial of ZD9331 given as a 30 minute infusion on days 1 and 8 with cycles repeated every 3 weeks. UCL Discovery (University College London). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact